» Articles » PMID: 27535945

Rapid Phenotyping of Knockout Mice to Identify Genetic Determinants of Bone Strength

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 2016 Aug 19
PMID 27535945
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The genetic determinants of osteoporosis remain poorly understood, and there is a large unmet need for new treatments in our ageing society. Thus, new approaches for gene discovery in skeletal disease are required to complement the current genome-wide association studies in human populations. The International Knockout Mouse Consortium (IKMC) and the International Mouse Phenotyping Consortium (IMPC) provide such an opportunity. The IKMC generates knockout mice representing each of the known protein-coding genes in C57BL/6 mice and, as part of the IMPC initiative, the Origins of Bone and Cartilage Disease project identifies mutants with significant outlier skeletal phenotypes. This initiative will add value to data from large human cohorts and provide a new understanding of bone and cartilage pathophysiology, ultimately leading to the identification of novel drug targets for the treatment of skeletal disease.

Citing Articles

Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis.

Zhou S, Sosina O, Bovijn J, Laurent L, Sharma V, Akbari P Nat Genet. 2023; 55(8):1277-1287.

PMID: 37558884 DOI: 10.1038/s41588-023-01444-5.


Knockout of murine Lyplal1 confers sex-specific protection against diet-induced obesity.

Vohnoutka R, Kuppa A, Hegde Y, Chen Y, Pant A, Tohme M J Mol Endocrinol. 2023; 70(3).

PMID: 36748836 PMC: 10947332. DOI: 10.1530/JME-22-0131.


Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation.

Kim A, Girgis C, McDonald M Curr Osteoporos Rep. 2022; 20(6):505-515.

PMID: 36201122 PMC: 9718877. DOI: 10.1007/s11914-022-00756-5.


Functional Validation of Osteoporosis Genetic Findings Using Small Fish Models.

Kague E, Karasik D Genes (Basel). 2022; 13(2).

PMID: 35205324 PMC: 8872034. DOI: 10.3390/genes13020279.


Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques.

Rauner M, Foessl I, Formosa M, Kague E, Prijatelj V, Lopez N Front Endocrinol (Lausanne). 2021; 12:731217.

PMID: 34938269 PMC: 8686830. DOI: 10.3389/fendo.2021.731217.


References
1.
Keen R, Hart D, Arden N, Doyle D, Spector T . Family history of appendicular fracture and risk of osteoporosis: a population-based study. Osteoporos Int. 1999; 10(2):161-6. DOI: 10.1007/s001980050211. View

2.
Delany A, Amling M, Priemel M, Howe C, Baron R, Canalis E . Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 2000; 105(7):915-23. PMC: 377474. DOI: 10.1172/JCI7039. View

3.
Frattini A, Orchard P, Sobacchi C, Giliani S, Abinun M, Mattsson J . Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet. 2000; 25(3):343-6. DOI: 10.1038/77131. View

4.
Brunkow M, Gardner J, Van Ness J, Paeper B, Kovacevich B, Proll S . Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet. 2001; 68(3):577-89. PMC: 1274471. DOI: 10.1086/318811. View

5.
Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M . Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001; 10(5):537-43. DOI: 10.1093/hmg/10.5.537. View